My Lymphoma tumor markers are rising — what does this mean
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Rising Lymphoma Tumor Markers
I understand this is concerning news. Let me help you understand what rising tumor markers generally mean and what questions to ask your care team.
What Tumor Markers Tell Us
Tumor markers are substances (usually proteins or DNA) that cancer cells produce or that your body makes in response to cancer. When these markers are rising, it typically suggests:
- Increased cancer cell activity — More cancer cells may be present or growing
- Potential disease progression — The lymphoma may not be responding as well to current treatment, or it may be returning
- Need for evaluation — Your doctor will want to investigate further with imaging and other tests
According to NCCN Guidelines for Marginal Zone Lymphomas, mutation testing and biomarker analysis are important because they can show changes in cancer cells over time. As the guidelines note, "subtle new drug-resistant mutations may occur over time. Mutations can also happen during treatment."
What This Doesn't Automatically Mean
Rising markers alone don't automatically mean:
- Your treatment has failed
- Your situation is hopeless
- A specific treatment is no longer working
- You need immediate treatment changes
Your complete clinical picture matters — imaging results, how you're feeling, your treatment history, and other factors all inform your doctor's interpretation.
Important Next Steps: Questions to Ask Your Oncologist
-
Which specific tumor markers are rising, and by how much? (Ask for the actual numbers and how they compare to previous results)
-
What imaging or additional tests do you recommend to evaluate this? (PET/CT scans or other imaging help confirm what's happening)
-
Could this be related to treatment side effects or inflammation rather than cancer progression? (Sometimes other factors can affect marker levels)
-
If this indicates disease progression, what are my treatment options? (Your doctor can discuss whether to continue, modify, or change your current approach)
-
How often will you monitor these markers going forward? (Understanding your surveillance plan helps you stay informed)
-
Are there any clinical trials that might be appropriate for my situation? (The National Cancer Institute (NCI) maintains a database of clinical trials at clinicaltrials.gov)
What Happens Next
Your oncologist will likely:
- Review your imaging studies (CT, PET/CT, or MRI scans)
- Consider your treatment response so far
- Evaluate your symptoms and how you're feeling
- Discuss whether your current treatment plan should continue, change, or if new approaches should be considered
According to NCCN Guidelines, imaging tests like PET/CT scans are standard tools to assess lymphoma response and help guide treatment decisions.
Moving Forward
This is a moment to have an open, detailed conversation with your care team. Bring a list of your questions, and don't hesitate to ask them to explain anything you don't understand. If you want a second opinion, that's also completely reasonable.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Lymphoma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: